INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ:AMEX Investor Relations:
ir.inovio.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of per share and pre-funded warrants to purchase 2,135,477 shares of its common stock at an offering price of per pre-funded warrant, in each case before underwriting discounts and commissions. Gross proceeds to INOVIO from the offering are expected to be approximately $36 million , before deducting underwriting discounts and commissions and estimated offering expenses payable by INOVIO . The offering is expected to close on or about April 18, 2024 , subject to customary closing conditions. All of the securities are being sold by INOVIO The offering was led by Deep Track Capital. Oppenheimer & Co. and Citizens JMP are acting as joint book-running managers for the offering. The securities were offered by INOVIO pursuant to an effective shelf re
Show less
Read more
Impact Snapshot
Event Time:
INO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INO alerts
High impacting Inovio Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
INO
News
- INOVIO to Participate in Upcoming Investor Conferences in May [Yahoo! Finance]Yahoo! Finance
- INOVIO to Participate in Upcoming Investor Conferences in MayPR Newswire
- INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024PR Newswire
- PharmaJet's needle-free delivery system proves effective in published study [Yahoo! Finance]Yahoo! Finance
- Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation [Seeking Alpha]Seeking Alpha
INO
Earnings
- 3/6/24 - Beat
INO
Sec Filings
- 4/26/24 - Form SC
- 4/17/24 - Form 8-K
- 4/17/24 - Form 424B5
- INO's page on the SEC website